Leading paediatric oncologist coordinates ELPIDA Foundation humanitarian effort as Medochemie and government partners respond to critical medicine shortages.
Paediatric cancer treatment in resource-limited settings faces numerous challenges, with medicine shortages representing one of the most critical obstacles to effective care. Essential medications—antibiotics to prevent infections in immunocompromised children, analgesics for pain management, and antiemetic drugs to control chemotherapy-related nausea—can become unavailable, forcing clinicians to modify treatment protocols and potentially compromising patient outcomes.
This reality confronted healthcare professionals in Botswana earlier this year, where shortages of critical paediatric cancer medicines threatened the continuity of care for young patients. The challenge prompted a coordinated international response led by Professor Loizos G. Loizou, Cyprus’s pioneering paediatric oncologist and president of the ELPIDA Foundation for Children with Cancer and Leukaemia.
Join The European Business Briefing
New subscribers this quarter are entered into a draw to win a Rolex Submariner. Join 40,000+ founders, investors and executives who read EBM every day.
SubscribeThrough his Cyprus International Action Plan for Childhood Cancer (Cy-IAPCC), Professor Loizou mobilized Cyprus’s medical expertise, pharmaceutical industry resources including Medochemie’s manufacturing capabilities, and support to deliver nearly two tonnes of essential medicines to Botswana in July 2025.
Cyprus’s Astonishing Leadership in Global Paediatric Oncology
Professor Loizou’s role in coordinating the Botswana mission reflects three decades of work that has transformed Cyprus’s paediatric cancer capabilities. As Clinical Professor of Paediatrics, Paediatric Oncology/Haematology/Immunology at the University of Nicosia Medical School, he built Cyprus’s Paediatric Oncology program from its foundation in 1990, establishing the Paediatric Oncology Department at Archbishop Makarios III Hospital in Nicosia.
Cyprus now achieves an 82% cure rate for childhood cancer, ranking among the world’s top-performing countries despite beginning its paediatric oncology program only three decades ago. Through partnership with the Groupe Franco-Africain d’Oncologie Pédiatrique, Professor Loizou has extended expertise to 24 paediatric oncology centers across 18 French-speaking African countries, addressing disparities where cure rates in developing countries remain below 20% compared to over 80% in developed nations.
The International Society of Paediatric Oncology recently recognized Professor Loizou’s contributions by naming him an Ambassador for Children with Cancer and Leukaemia—an honour reserved for distinguished physicians with extensive experience in advancing paediatric cancer care worldwide.
Honouring his outstanding dedication to advancing the health and well-being of people worldwide, AHEPA (the American Hellenic Educational Progressive Association) has appointed Dr. Loizou as the AHEPA Global Health Ambassador. This is the first time in the Association’s 103-year history that such an appointment has been made.
ELPIDA Foundation’s Mission and International Reach
Professor Loizou’s humanitarian work operates through the ELPIDA Foundation for Children with Cancer and Leukaemia, established alongside Cyprus’s paediatric oncology program in 1990. The foundation’s mission reflects both clinical precision and humanitarian commitment: providing “overall care and support of the child with cancer and his family, with respect, love and dedication.”
The organization’s vision remains uncompromising: “No child should lose their life to cancer. Every child should have the opportunity to heal, grow and prosper.” This goal drives ELPIDA’s expanding international activities through the Cyprus International Action Plan on Childhood Cancer (Cy-IAPCC), which coordinates medicine deliveries, telemedicine programs, and physician training across multiple countries where paediatric oncology resources remain limited.
The Botswana mission exemplified this coordinated approach, with Professor Loizou working directly with paediatric oncologists and relevant authorities in Botswana to identify specific medical needs and organize an effective response.
Presidential Recognition and Government Support
The humanitarian mission received strong support from Cyprus’s highest political levels. President Nikos Christodoulides has consistently championed international collaboration in paediatric cancer care, positioning Cyprus’s medical expertise as a platform for humanitarian leadership.
Speaking at the International Conference of Experts on Childhood and Adolescent Cancer at the presidential palace in February 2025, President Christodoulides called for enhanced international collaboration. The President’s tribute to Professor Loizou captured government support for the initiative, describing him as one of Cyprus’ “greatest ambassadors in paediatric care” and observing that “the greatest remedy is love and humanity, and Dr Loizou embodies both.”
The Cyprus Foreign Affairs Ministry and CyprusAid provided significant financial support.
Pharmaceutical Industry Partnership
The mission’s success depended significantly on Cyprus’s pharmaceutical sector responding to Professor Loizou’s coordination efforts. Medochemie, Cyprus’s largest pharmaceutical company, emerged as a key partner with the manufacturing capabilities necessary to address the specific shortages identified by Botswana’s paediatric cancer specialists.
Operating 15 state-of-the-art production facilities across Cyprus, the Netherlands, and Vietnam, Medochemie provided both the manufacturing scale and quality standards essential for paediatric cancer treatments. When Professor Loizou’s coordination identified the specific medicines needed, Medochemie Chief Operating Officer Daphne Pittas authorized the company’s participation.
The pharmaceutical company provided antibiotics, pain relief medications, and antiemetic treatments specifically requested by Botswana’s medical teams. “Medochemie actively supports initiatives that save lives and promote global solidarity,” the company stated following the successful delivery.
International Recognition and Impact
The mission culminated in an official handover ceremony in Gaborone on July 10, 2025, where Botswana Health Minister Dr. Stephen Modise received the essential medicines on behalf of his country’s healthcare system.
“This is more than a shipment of medical supplies. It is an act of solidarity, partnership, and shared humanity that will bring hope to communities, especially those hardest hit by medicine shortages,” Minister Modise said during the ceremony. The Health Minister specifically acknowledged the collaborative effort: “We are grateful to the Elpida Foundation, Medochemie, Government, and people of Cyprus for this significant contribution to the health and well-being of our nation.”
The donated medicines will directly benefit public hospitals and clinics across Botswana, with priority given to facilities in underserved and rural areas. “This consignment of two tons of essential medicines will ease the burden on our healthcare workers and provide essential relief to patients who have gone without critical medications for too long,” Minister Modise noted.
Building Sustainable Healthcare Partnerships
Beyond immediate humanitarian relief, Professor Loizou’s approach reflects his broader strategy for addressing global paediatric cancer challenges through sustainable international partnerships. The ELPIDA Foundation operates across five strategic areas: medicine and equipment delivery, education and prevention programs, telemedicine services, physician training, and humanitarian support.
The success of Professor Loizou’s initiative positions Cyprus as an emerging hub for coordinated international medical assistance. The country’s medical expertise, pharmaceutical industry capabilities, and government commitment to medical diplomacy create a platform for addressing global health challenges.
For countries like Botswana, partnerships coordinated through experts like Professor Loizou provide access to medical knowledge and pharmaceutical resources that might otherwise remain unavailable, while creating relationships that support ongoing healthcare system strengthening.
Minister Modise noted that the donation represents “part of a growing strategic partnership between civil society, industry, and the governments of Botswana and Cyprus,” creating potential templates for expanded medical cooperation addressing similar healthcare challenges across Africa.
